The global biologics market is expected to reach USD 477.15 Billion by 2027, according to a new report by Emergen Research. The Biologics market is experiencing a rapid growth attributable to a growing demand for monoclonal antibodies, recombinant hormones/proteins, gene-based & cellular-based biologics, vaccines, and molecular therapy, among others, in the treatment of diseases including cancer, infectious diseases, immunological diseases, cardiovascular diseases, and hematological diseases, among others. Besides, growing demand and higher adoption of novel therapies across the globe for the treatment of disease conditions is a significant factor causative of the growing market demand.

Growing use of biologics for the treatment of autoimmune diseases, comprising various arthritis types, including ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis, is playing a crucial role in driving the growth of the market. Biologics function by creating an inflammation disruption, thereby resulting in a reduction in joint pain.

The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment. Therefore, the report fully covers the profound impact of COVID-19 on this industry, with a special focus on the affected industry segments. The latest research report can be viewed as a valuable source of viable data and information pertaining to this particular business vertical. It provides a complete overview of the Biologics industry, considering the future growth analysis, demand, and supply graphs, as well as historical and future costs and revenue generation.

Download the Complete Sample report description: https://www.emergenresearch.com/request-sample/61

Additionally, the swiftly growing burden of chronic diseases across the globe are fueling market growth. According to the statics released by WHO (World Health Organization), the burden of chronic diseases is projected to grow by 57.0% by the year 2020 from 2001. Developing nations are expected to be highly impacted, contributing to 60.0% of the global burden of chronic diseases.

The global Biologics market study covers the current COVID-19 scenario that has turned the global business sphere upside down. The coronavirus has resulted in a major economic downturn worldwide, while also adversely impacting the growth of this industrial sector. The pandemic has brought about drastic changes in market conditions.

With a major focus on the growth trajectories of each segment of the market, the report inspects the operating patterns of each market contender, for instance, partnerships & collaborations, mergers & acquisitions, and new product launches, in a detailed manner.

Key participants include Novo Nordisk A/S, Pfizer Inc., Amgen, Sanofi, Samsung BioLogics, Merck & Co. Inc., Celltrion, AbbVie Inc., Johnson & Johnson Services Inc., and GlaxoSmithKline, among others.

To make an inquiry, Visit Here: https://www.emergenresearch.com/purchase-enquiry/61

It offers a lucid picture of current trends in the global market, with an unbiased perspective of the leading market players, key regions/countries, end-use industries, and various product types.

By application, cancer, in terms of revenue, contributed to the largest market share in 2019. Biologics assists the immune system in quickly recognizing the cancer cells in the human body, as well as attacking the malignant cells, switching on/off the signals from cancerous cells helping in dodging the immune system cells.

Source Outlook (Revenue, USD Billion; 2017-2027)

  • Microbial
  • Mammalian
  • Others

Type Outlook (Revenue, USD Billion; 2017-2027)

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Hormones/Proteins
  • Cellular-Based Biologics
  • Gene-Based Biologics
  • Others

Application Outlook (Revenue, USD Billion; 2017-2027)

  • Cancer
  • Infectious Diseases
  • Immunological Diseases
  • Cardiovascular Diseases
  • Haematological Disorders
  • Others

The market intelligence report exhaustively examines the market value, share, demand, growth prospects, latest and historical trends, manufacturers, gross revenue collection, competitive terrain, market growth forecast, available products, and end-use applications.

To identify the key trends in the industry, click on the link below: https://www.emergenresearch.com/industry-report/biologics-market

The market in the Asia Pacific region is likely to grow at the fastest rate of 8.9% in the period 2019-2027, due to the improving healthcare infrastructure, rising investments in biologics development, and better reimbursement scenario.

Regional Outlook (Revenue, USD Billion; 2017-2027)

  • North America
    • S
    • Canada
  • Europe
    • Germany
    • K
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • MEA
    • Saudi Arabia
    • UAE
    • Rest of MEA

 Key questions addressed in the report:

  • What are the key factors driving the global Biologics market?
  • Who are the key manufacturers in this market space?
  • Who are the distributors, traders and dealers of this market?
  • What are the market opportunities and risks affecting the performance of the vendors in the global Biologics market?

Request a customized copy of the report: https://www.emergenresearch.com/request-for-customization/61

Global Biologics Market Report – Table of Contents:

Chapter 1. Methodology & Sources

1.1. Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Biologics Market Segmentation & Impact Analysis

4.1. Biologics Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Market indicators analysis

4.2.2. Market drivers analysis

4.2.2.1. Growing occurrences of target conditions

4.2.2.2. Growing geriatric population

4.2.2.3. Advancement in biomedical technology

4.2.2.4. Surging demand and higher adoption of novel therapies

4.2.3. Market restraints analysis

4.2.3.1. Biosimilars development

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 5. Biologics Market By Source Insights & Trends, Revenue (USD Million)

5.1. Source Dynamics & Market Share, 2019 & 2027

5.1.1. Microbial

5.1.2. Mammalian

5.1.3. Others

Chapter 6. Biologics Market By Type Insights & Trends Revenue (USD Million)

6.1. Type Dynamics & Market Share, 2019 & 2027

6.1.1. Monoclonal Antibodies

6.1.2. Vaccines

6.1.3. Recombinant Hormones/Proteins

6.1.4. Cellular-Based Biologics

6.1.5. Gene-Based Biologics

6.1.6. Others

Chapter 7. Biologics Market By Application Insights & Trends Revenue (USD Million)

7.1. Application Dynamics & Market Share, 2019 & 2027

7.1.1. Cancer

7.1.2. Infectious Diseases

7.1.3. Immunological Diseases

7.1.4. Cardiovascular Disorders

7.1.5. Haematological Disorders

7.1.6. Others

Continue..!

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkdIn | Twitter | Blogs

Leave a comment

Your email address will not be published. Required fields are marked *